12
landing page
FasterCures and COVID-19
Ending the Crisis
The goal of FasterCures is to understand how industry and government are working
to end the COVID-19 crisis. To help us in this mission, we have created Four Pillars., FasterCures: COVID-19 Action Recommendations
Learn More About the Recommendations
+ Read More
person
Tanisha Carino
panel
FasterCures Roundtable (Invite only)
As health systems worldwide recover and rebuild in the retention wake of COVID-19, the importanc
e of early preparation, multi-stakeholder collaboration, and constant innovation must not be forgotten.
+ Read More
article
FasterCures Quarterly Newsletter
In this Issue
Responding to COVID-19—A Gamechanger for Everyone»
report
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts
FasterCures is advancing system change within biomedical research to focus on and value diversity a
nd representation within clinical trials and the workforce.
+ Read More
report
Consortia-pedia Framework Report
FasterCures initiated the Consortia-pedia project to better understand the breadth and scope of app
roaches that a wide range of consortia have adopted to bring together nontraditional partners with a shared R&D goa
+ Read More
report
Unlocking Intellectual Property: Principles for Responsible Negotiation
FasterCures convened a small Intellectual Property (IP) expert panel in July 2012 to develop a
set of guiding principles and points to consider that can serve as a useful tool for all parties
+ Read More
report
University-Foundation Relations: From Transactional to Transformative Partnerships
In biomedical research, both nonprofit disease foundations and academic research institutions are c
ommitted to translating research into effective therapies for patients.
+ Read More
report
Cornerstones of Collaboration: Foundation-Led Partnerships to Accelerate R&D
Multi-stakeholder collaboration isn’t just the participation trophy of biomedical research and deve
lopment (R&D), a nice way to make sure everyone feels included.
+ Read More
video
Advances in Science: Beyond “One Disease at a Time:” Therapeutic Platforms for Monogenic Disease
Guest speaker Philip John (P.J.) Brooks, PhD, acting director of the Division of Rare Diseases Res
earch Innovation at the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) delivered a presentation about cell an
+ Read More
article
Letter of Support: Reauthorization of Food and Drug Administration (FDA) User Fee Programs
Submitted electronically
article
Closing the Gap: How an Innovative Funding Model Is Delivering Hope
It is estimated that 25,000-50,000 Americans have a debilitating skin disorder called epidermol
ysis bullosa (EB).
+ Read More